Winicker Norimed GmbH
14
0
1
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
35.7%
5 terminated/withdrawn out of 14 trials
54.5%
-32.0% vs industry average
14%
2 trials in Phase 3/4
17%
1 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Influence of Variable Inflow Volume, Dwell Duration and Glucose Concentration on Ultrafiltration Volume in APD Patients
Role: collaborator
Non-interventional Study in Pediatric Patients Treated With NOVOCART Inject in the Knee
Role: collaborator
Non-interventional Study With NOVOCART® 3D for the Treatment of Cartilage Defects of the Knee in Pediatric Patients
Role: collaborator
Early Extubation by ECCO2R Compared to IMV in Patients with Severe Acute Exacerbation of COPD
Role: collaborator
Therapy for Scabies With Two Differently Concentrated Permethrin Creams
Role: collaborator
Safety and Performance Evaluation of multiPlus Dialysate During CRRT
Role: collaborator
Comparison of Efficacy and Tolerability of APD Treatment With Different PD Cyclers
Role: collaborator
REVIparin-BRIDging-in a General Practice Setting in GErmany
Role: collaborator
Escalated Therapy of Scabies With INFECTOSCAB 5% (Permethrin)
Role: collaborator
Non-interventional Study With NOVOCART® Basic in Patients Treated for Cartilage Defects in the Knee With MAC
Role: collaborator
Non-interventional Study With NOVOCART® Inject in the Reconstruction of the Knee Cartilage Defects
Role: collaborator
Effects of the NO-synthase Inhibitor VAS203 on Renal Function in Healthy Volunteers
Role: collaborator
Initial Oral Vinorelbine Dosing Schedules in Clinical Routine in Germany and Austria
Role: collaborator
Determination In-vivo KUF for Diacap Pro Hemodialyser
Role: collaborator
All 14 trials loaded